Literature DB >> 9181753

Soluble markers of endothelial cell function.

A Blann1, M Seigneur.   

Abstract

Damage to the endothelium is believed to be important in the development and progression of atherosclerosis. Consequently, vascular biologists are seeking good markers of endothelial cell function which hope to provide tools to dissect the role of these cells in disease. This review will examine a number of endothelial cell products (thrombomodulin, von Willebrand factor and soluble E-selectin) and discuss their value as markers of vascular integrity.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9181753

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN： 1386-0291            Impact factor:   2.375


  13 in total

1.  Characterization of von Willebrand factor in primary pulmonary hypertension.

Authors:  M T Collados; J Sandoval; S López; F A Massó; A Páez; J R Borbolla; L F Montaño
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Association of ATP1B1, RGS5 and SELE polymorphisms with hypertension and blood pressure in African-Americans.

Authors:  Mezbah U Faruque; Guanjie Chen; Ayo Doumatey; Hanxia Huang; Jie Zhou; Georgia M Dunston; Charles N Rotimi; Adebowale A Adeyemo
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

3.  Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes.

Authors:  Lu Qi; Marilyn C Cornelis; Peter Kraft; Majken Jensen; Rob M van Dam; Qi Sun; Cynthia J Girman; Cathy C Laurie; Daniel B Mirel; David J Hunter; Eric Rimm; Frank B Hu
Journal:  Hum Mol Genet       Date:  2010-02-10       Impact factor: 6.150

4.  Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage.

Authors:  Verónica Inés Landoni; Jose R Pittaluga; Agostina Carestia; Luis Alejandro Castillo; Marcelo de Campos Nebel; Daiana Martire-Greco; Federico Birnberg-Weiss; Mirta Schattner; Pablo Schierloh; Gabriela C Fernández
Journal:  Front Cell Infect Microbiol       Date:  2022-06-23       Impact factor: 6.073

5.  Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells.

Authors:  C M Radder; H Beekhuizen; H H H Kanhai; A Brand
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

6.  Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.

Authors:  G F de Larrañaga; S D A Perés Wingeyer; L M Puga; B S Alonso; J A Benetucci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-02       Impact factor: 3.267

7.  Sympathoadrenal activation and endothelial damage are inter correlated and predict increased mortality in patients resuscitated after out-of-hospital cardiac arrest. a post Hoc sub-study of patients from the TTM-trial.

Authors:  Pär I Johansson; John Bro-Jeppesen; Jesper Kjaergaard; Michael Wanscher; Christian Hassager; Sisse R Ostrowski
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

8.  Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study.

Authors:  Sisse Rye Ostrowski; Nicolai Haase; Rasmus Beier Müller; Morten Hylander Møller; Frank Christian Pott; Anders Perner; Pär Ingemar Johansson
Journal:  Crit Care       Date:  2015-04-24       Impact factor: 9.097

9.  Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines.

Authors:  Sisse R Ostrowski; Sune H Pedersen; Jan S Jensen; Rasmus Mogelvang; Pär I Johansson
Journal:  Crit Care       Date:  2013-02-22       Impact factor: 9.097

10.  How biomarkers reflect the prognosis and treatment of necrotising soft tissue infections and the effects of hyperbaric oxygen therapy: the protocol of the prospective cohort PROTREAT study conducted at a tertiary hospital in Copenhagen, Denmark.

Authors:  Peter Polzik; Pär I Johansson; Ole Hyldegaard
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.